Proposal 1 Do you agree with the proposal to report Traded Options when matched on the market data feed LMEselectMD?
|
|
- Gabriel Reynolds
- 5 years ago
- Views:
Transcription
1 Appendix 1 Summary of Feedback and Responses Proposal 1 Do you agree with the proposal to report Traded Options when matched on the market data feed LMEselectMD? Respondent 1 The respondent is in favour of this proposal. Noted. Yes Respondent 2 The respondent is generally in favour of this proposal but would like clarification on two points: 1. The respondent has concerns over the timescale for the implementation of the new reporting regime and has requested details of the reporting window far in advance of the implementation date. 2. The respondent would also like clarification that this proposal will only be for Member-to-Member trades. The LME acknowledges the respondent s comments and provides the following clarity on the two points raised: 1. The LME will provide at least three months notice before any agreed changes are implemented. 2. For consistency, the proposal to report Traded Options on the LME market data feed (LMEselectMD) will include Client trades. This is in addition to Member-to-Member trades for both the Inter-office and LMEselect trading venues. A similar approach will be taken with the proposal to report Futures trades, which will additionally include Ring business. Yes/No Respondent 3 The respondent is in favour of this proposal. Noted. Yes Respondent 4 The respondent agrees with the rationale to report transactions for Traded Options when they are matched on a real-time basis. However, the respondent s preference is to exclude Client trades from these reports. The LME acknowledges the respondent s comments. The LME believes that the inclusion of reporting Client transactions for both Futures and Options on a real-time basis, which is consistent with the proposal to report Member-to-Member transactions, will provide market participants with a more comprehensive and structured Yes/No
2 transparency regime for the LME. This in turn may promote and incentivise more participation on the LME. The LME would like to reiterate that Client and Member trades will not be displayed separately on the LME market data feed and there will be no trade-type identifier. Therefore, while there will be greater market transparency, it will not be possible to tell whether the reported trade is derived from a Client or Member. Respondent 5 The respondent is in favour of this proposal. The respondent references a previous correspondence from them to the LME and reiterates that Client accountability should be the same as it is for Members. The LME acknowledges the comments of the respondent. The LME would also like to further clarify that the proposal to publish transactions for Traded Options on the LME market data feed includes Client and Member trades for both Futures and Options on a real-time basis. The LME believes that this will provide a higher level of consistency and transparency for all market participants. Yes Respondent 6 The respondent is supportive in establishing a consistent approach to transaction reporting, but given client feedback received, believes further consideration is required to find a suitable solution at a time when the value of the LME client contract is being questioned. The LME acknowledges the comments of the respondent, but must consider under MiFID II it will be obliged to report transactions on a real-time basis. The LME believes that the inclusion of reporting Client transactions for both Futures and Options on a real-time basis, which is consistent with the proposal to report Member-to-Member transactions, will provide market participants with a more comprehensive and structured transparency regime for the LME. This in turn may promote and incentivise more participation on the LME. No
3 Respondent 7 The respondent has requested confirmation of the level of trade detail that will be published in the real time reporting of Traded Options. The respondent has expressed a request for a level of protection in favour of Market Makers, removing the Vol and Price of trades from the reports. The LME acknowledges the respondent s comments and would like to clarify that the following trade details will be reported: Trade Time, Metal, Description, Price and Size. The LME believes that a level of protection will be provided to Market Makers in the form of deferred publication of large trades. Proposal 2 Do you agree with the proposal to remove the logic to defer the reporting of large trades by 2 business days? Respondent 1 The respondent strongly supports this proposal. Noted. Yes Respondent 2 The respondent states that they have a preference to remain with the current logic of deferring large in scale trades for two business days. The respondent does note, however, that under new regulations for MiFID II this may not be possible. The respondent concludes that, until the new regulatory requirements are clarified, they feel that large trades should continue to be deferred for two business days. The LME acknowledges the respondent s comments. The LME will apply to the FCA for a waiver to enable it to keep the deferral for large in scale trades if it resolved through this consultation that this should be the way forward. At this stage the final details of deferrals permitted under MiFID II have yet to be clarified. No
4 Respondent 3 The respondent does not agree with the proposal to remove the logic to defer the reporting of large trades. The respondent further comments that the LME and Traded Options Committee spent considerable time debating and implementing the deferred publication of large trades. Therefore, the removal of this logic may question why it was introduced originally. The respondent also indicates that the current method protects the market makers position in a market which is not particularly liquid. The LME acknowledges the respondent s comments. If the LME does intend to continue with deferred publication under MiFID II, it will need to apply for a waiver from the FCA to continue with this method of reporting Options transactions that are large in scale. It will, however, be likely that the LME will still be required to publish price and instrument on the relevant trade day at 7.00 pm, with the volume being deferred until around 7.00 pm after two business days. No Respondent 4 The respondent is in favour of this proposal. Noted. Yes Respondent 5 The respondent does not agree with the proposal to remove the logic to defer the reporting of large trades. The respondent makes reference to previous discussions around the introduction of the deferred publication of large trades, and the subsequent amendments to the definition of large in scale trades. While the process originally deemed anything over 100 lots as a large trade, these thresholds were then adjusted following discussions with the Traded Options Committee. The respondent questions the LME s rationale in proposing to remove the deferred publication of large trades after only one year and asks for The LME notes the respondent s comments. The LME acknowledges that the introduction of this process arose from discussions within the Traded Options Committee and other market participants. The LME would like to note that when the deferral of large in scale trades was introduced, the full implications of regulatory change around this reporting methodology were unclear at the time. However, through discussions with market participants it was felt prudent to carry on with this reporting regime until a more suitable methodology could be considered at the appropriate opportunity. Through this consultation, the LME welcomes comments from market participants on this issue so the LME can gauge general views and opinions. The LME No
5 clarification on this. does have the ability to request a waiver from the FCA, although the exact details of any deferral that may be granted are unclear at this stage. Respondent 6 The respondent has no comment. Noted. Respondent 7 The respondent has no comment. Noted. Proposal 3 Do you agree with the proposal to decommission the batched Options Matched Trades reports? Respondent 1 The respondent supports this proposal and has requested that the LME works with Bloomberg to ensure that their LMPM page collates the realtime data correctly and in a timely manner. The LME notes these comments and is working closely with Bloomberg and other market data vendors to ensure that all relevant reports for Options matched trade data will be published correctly and in the appropriate format. Yes Respondent 2 The respondent supports this proposal. Noted. Yes Respondent 3 The respondent supports this proposal. Noted. Yes
6 Respondent 4 The respondent supports this proposal. Noted. Yes Respondent 5 The respondent has no comment. Noted. Respondent 6 The respondent has no comment. Noted. Respondent 7 The respondent has no comment. Noted. Proposal 4 Do you agree with the proposal to publish Options Open Interest on the next business day? Respondent 1 The respondent supports this proposal. Noted. Yes Respondent 2 The respondent supports this proposal but has a preference to remain with the current methodology of publishing Open Interest for large trades after two business days. The LME acknowledges the respondent s comments but would also state that from previous discussions a large proportion of market participants are in favour for the reporting of Options Open Interest on the next business day as this gives greater transparency particularly leading up to the relevant options expiry. Yes/No
7 Respondent 3 The respondent supports this proposal. Noted. Yes Respondent 4 The respondent is in favour of this proposal. Noted. Yes Respondent 5 The respondent has no comment. Noted. Respondent 6 The respondent has no comment. Noted. Respondent 7 The respondent has no comment. Noted. Proposal 5 Do you agree with the proposal to report Client Futures when matched on the market data feed LMEselectMD? Respondent 1 The respondent supports this proposal. Noted. Yes Respondent 2 The respondent supports this proposal. Noted. Yes
8 Respondent 3 The respondent supports this proposal. Noted. Yes Respondent 4 The respondent supports this proposal. Noted. Yes Respondent 5 The respondent has no comment. Noted. Respondent 6 The respondent has no comment. Noted. Respondent 7 The respondent has no comment. Noted. Proposal 6 Are there any other matters which you believe the Exchange should take into account in relation to the Proposals? Respondent 1 The respondent confirms their earlier point and has requested that the LME work with Bloomberg to ensure that the LMEO (Open Interest) and the LMPM pages are set up correctly and can display the data being sent by the LME in a timely and precise manner. The LME notes these comments and acknowledges the respondent s comments. The LME is already in constructive dialogue with Bloomberg and will work closely to ensure a successful implementation, if adopted. Yes
9 Respondent 2 The respondent has concerns over the number of reporting changes for LME products which is a burden on their internal resources. The respondent s view is that the LME should be focussing more on reviewing their settlement process. However, the respondent acknowledges that if these proposed changes are agreed as a result of general discussion and the views of the Trading Options Committee, then they will be implemented. The respondent emphasises that any reporting changes are clarified to the market and that the advanced notice of implementation is made transparent to the whole market. The LME notes and acknowledges the respondent s comments around the large number of reporting changes. However, the LME is looking to take a structured and comprehensive approach with the Proposals in this consultation which it believes will ultimately be more consistent and easier to digest for all market participants. In addressing the comments on settlement procedures, the LME has recently issued a decision notice on four enhancements that it believes will strengthen and enhance the determination of the Closing Prices for Traded Options. The LME also believes the procedures used both on the Ring and electronically for the determination of Futures Reference Prices are robust. The LME has introduced a number of rule and procedural changes both before and after the Board review of the Ring in 2014 that have strengthened the methodology for establishing both the Official and Closing Prices. Yes Respondent 3 The respondent indicates that they feel the LME should apply for a waiver to the FCA in order to allow the deferral of large trades to continue. The LME acknowledges the respondent s comments and any decision on applying for the waiver will come after the conclusion of this consultation. Respondent 4 The respondent has no further comment at this time. Noted.
10 Respondent 5 The respondent has no further comment at this time. Noted. Respondent 6 The respondent has no further comment at this time. Noted. Respondent 7 The respondent has no further comment at this time. Noted.
CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND
CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:
More informationBackground EVM. FAO/WHO technical workshop on nutrient risk assessment, Geneva, May 2005, published 2006.
UK GOVERNMENT RESPONSE TO THE EUROPEAN COMMISSION S DISCUSSION PAPER ON THE SETTING OF MAXIMUM AND MINIMUM AMOUNTS FOR VITAMINS AND MINERALS IN FOODSTUFFS. Background The United Kingdom (UK) Government
More informationPGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne
Public consultation on Delegated Act on Post-Authorisation efficacy studies PGEU RESPONSE INTRODUCTION The Pharmaceutical Group of the European Union (PGEU) is the association representing community pharmacists
More informationEUROPEAN COMMISSION. Modus Operandi for the management of new food safety incidents with a potential for extension involving a chemical substance
EUROPEAN COMMISSION Modus Operandi for the management of new food safety incidents with a potential for extension involving a chemical substance The Health and Consumer Protection Directorate-General of
More informationHearing aid dispenser approval process review Introduction Hearing aid dispenser data transfer... 6
Hearing aid dispenser approval process review 2010 11 Content 1.0 Introduction... 4 1.1 About this document... 4 1.2 Overview of the approval process... 4 2.0 Hearing aid dispenser data transfer... 6 2.1
More informationISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations
Agenda Item 1-A ISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations Introduction 1. Since the September 2016
More informationProfessional Conduct Department User Satisfaction Survey of Complainants and Barristers. Annual Report 2010
Professional Conduct Department User Satisfaction Survey of Complainants and Barristers Annual Report 2010 September 2011 Contents Introduction... 3 Methodology... 3 Response Rates... 3 Supplementary Research
More informationThe EU PIP - a step in Pediatric Drug Development. Thomas Severin Bonn,
The EU PIP - a step in Pediatric Drug Development Thomas Severin Bonn, 13.01.2009 Agenda Implications for Industry Company Preparation Time of PIP Submission Content of the PIP The PIP Process and first
More informationSummary of responses: Consultation on determining the amount of a variable monetary penalty. April 2017
Summary of responses: Consultation on determining the amount of a variable monetary penalty April 2017 1. Introduction 1.1 One of SEPA s most important roles, as Scotland s principal environmental regulator,
More informationMedical Devices. UKRAINE Magisters
Medical Devices UKRAINE Magisters CONTACT INFORMATION Oleg Boichuk, Senior Associate Oleksandr Liulkov, Associate Magisters 38 Volodymyrska St., Kyiv, Ukraine +38044 492 82 82 www.magisters.com 1. Definition
More informationUSE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE
NHS Scotland Directors of Pharmacy and Scottish Association of Medical Directors USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE CONSENSUS STATEMENT This consensus
More informationSTANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 15 July 2009
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 15 July 2009 Chairman: Mr Basil
More informationSUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section General Food Law)
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Brussels, SANCO E 1718316 SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section
More informationThe Welsh Government will ask people in health and social services to:
Welsh Government consultation on 'More than just words.follow-on Strategic Framework for Welsh Language Services in Health, Social Services and Social Care. The strategy hopes to increase the use of Welsh
More informationRe: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org August 25, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,
More informationThe legal basis of this draft Regulation is Art. 11 (4) of Regulation (EC) No. 882/2204.
SANCO D1(06)D/413447 SUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 14 DECEMBER 2006 SECTION TOXICOLOGICAL SAFETY OF THE FOOD CHAIN President : Mrs Patricia
More informationEHR Developer Code of Conduct Frequently Asked Questions
EHR Developer Code of Conduct Frequently Asked Questions General What is the purpose of the EHR Developer Code of Conduct? EHR Association (the Association) members have a long tradition of working with
More informationUNITED STATES OF AMERICA BEFORE THE FEDERAL ENERGY REGULATORY COMMISSION. Portland General Electric Company ) Docket No.
UNITED STATES OF AMERICA BEFORE THE FEDERAL ENERGY REGULATORY COMMISSION Portland General Electric Company ) Docket No. ER17-1075-000 MOTION TO INTERVENE AND COMMENTS OF THE CALIFORNIA INDEPENDENT SYSTEM
More informationACCESS TO DENTAL CARE FOR BRISTOL STUDENTS
ACCESS TO DENTAL CARE FOR BRISTOL STUDENTS Healthwatch engaged with students studying at Bristol University to find out students experiences of using local dental services. The questionnaire aimed to identify
More informationInternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
Final Concept Paper E9(R1): Addendum to Statistical Principles for Clinical Trials on Choosing Appropriate Estimands and Defining Sensitivity Analyses in Clinical Trials dated 22 October 2014 Endorsed
More informationRe: May 2018 Consultation Paper, Professional Skepticism Meeting Public Expectations
Chartered Professional Accountants of Canada 277 Wellington Street West Toronto ON CANADA M5V 3H2 T. 416 977.3222 F. 416 977.8585 www.cpacanada.ca Comptables professionnels agréés du Canada 277, rue Wellington
More informationExhibit 2 RFQ Engagement Letter
Exhibit 2 RFQ 17-25 Engagement Letter The attached includes the 6 page proposed engagement letter to be used by HCC. ENGAGEMENT LETTER Dear: [Lead Counsel/Partner] We are pleased to inform you that your
More informationRE: IESBA s Exposure Draft Proposed Revisions Pertaining to Safeguards in the Code Phase 1
31 March 2016 Mr. Ken Siong Technical Director International Ethics Standards Board for Accountants (IESBA) International Federation of Accountants (IFAC) 529 Fifth Avenue, 6 th Floor New York, New York
More informationComments on Consultative Report Governance arrangements for critical OTC derivatives data elements (other than UTI and UPI)
September 27, 2018 Secretariats of The Committee on Payments and Market Infrastructures The International Organization of Securities Commissions Comments on Consultative Report Governance arrangements
More informationBoard Meeting Date of Meeting: Wednesday 3 rd May, 2017
Board Meeting Date of Meeting: Wednesday 3 rd May, 2017 Healthwatch Birmingham Board Meeting Time: 4.30 pm 6.30 pm Venue: Healthwatch Birmingham Board Room Cobalt Square, 83 Hagley Road, Birmingham, B16
More informationResponse to: Concept paper of 9 February 2011 submitted for public consultation by the European Commission on the
Response to: Concept paper of 9 February 2011 submitted for public consultation by the European Commission on the REVISION OF THE CLINICAL TRIALS DIRECTIVE 2001/20/EC Submitted by the European AIDS Treatment
More informationCOMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES
COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental
More informationBACKGROUND + GENERAL COMMENTS
Response on behalf of Sobi (Swedish Orphan Biovitrum AB) to the European Commission s Public Consultation on a Commission Notice on the Application of Articles 3, 5 and 7 of Regulation (EC) No. 141/2000
More information15 May 2017 Exposure Draft. Response Due Date 23 June Exposure Draft
15 May 2017 Exposure Draft Response Due Date 23 June 2017 Exposure Draft Proposed Application Material Relating to: (a) Professional Skepticism Linkage with the Fundamental Principles; and (b) Professional
More informationAnnual Report 2005 of the Mortality Forum
WHO-FIC 2005/ WHO-FIC NETWORK MEETING Abstract Annual Report 2005 of the Mortality Forum Lars Age Johansson WHO Collaborating Centre for the Family of International Classifications in the Nordic Countries,
More informationEUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 07 MARCH 2017
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL sante.ddg2.g.5(2017)1952268 SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 07 MARCH 2017 (Section
More informationBritish Columbia Data Standards
British Columbia Data Standards Minimum Immunization Data Set Interoperability Guide Version: 1.0 October 23, 2017 Sponsors PHSA: Jill Reedijk Canada Health Infoway DOCUMENT CONTROL DOCUMENT HISTORY Version
More informationGOOD PHARMACOPOEIAL PRACTICES
May 2013 RESTRICTED GOOD PHARMACOPOEIAL PRACTICES CONCEPT PAPER ON PURPOSE AND BENEFITS (MAY 2013) DRAFT FOR COMMENT Please address any comments on this proposal by 12 July 2013 to Dr S. Kopp, Medicines
More informationMānuka Honey Labelling Guidelines Work Group and Science Work Group Meeting Summary
Mānuka Honey Labelling Guidelines Work Group and Science Work Group Meeting Summary Tuesday 11 March 2014, The Terrace Conference Centre, 114 The Terrace, Wellington Chair: Scott Gallacher (guidelines
More informationConsistency in REC Review
National Research Ethics Advisors Panel Consistency in REC Review Summary 1. Consistency is taken to mean that, for any specific application or other, similar, applications, Research Ethics Committees
More informationFiona Campbell. ISA 315 (Revised) Responding to Comments to the Exposure Draft. Deputy Chair of the IAASB and Chair of the ISA 315 Task Force
ISA 315 (Revised) Responding to Comments to the Exposure Draft IAASB Meeting March 12 th, 2019 Fiona Campbell Deputy Chair of the IAASB and Chair of the ISA 315 Task Force Responses to ED-315 Broad concerns
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893
COUNCIL OF THE EUROPEAN UNION Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DLEG 51 CODEC 893 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: Common Position with
More informationXXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology
Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,
More information(Text with EEA relevance) (2014/798/EU)
L 330/50 COMMISSION IMPLEMTING DECISION of 13 November 2014 amending Annex F to Council Directive 64/432/EEC as regards the format of the model health certificates for intra-union trade in bovine animals
More informationARTEMIS. An integrated review service for radioactive waste and spent fuel management, decommissioning and remediation programmes
ARTEMIS An integrated review service for radioactive waste and spent fuel management, decommissioning and remediation programmes Learn more at www.iaea.org/artemis 14-31431 @ Table of Content What is ARTEMIS?................................
More informationEducation and Training Committee 15 November 2012
Education and Training Committee 15 November 2012 Review of the process of approval of hearing aid dispenser pre-registration education and training programmes. Executive summary and recommendations Introduction
More informationQUESTIONS: GENERAL. 2. Would it then be fair to say that TCF carries a lot of (confusing) duplication?
QUESTIONS: GENERAL 1. As a registered Financial Service provider one could hardly be compliant or fit and proper and not treat customers fairly particularly as regards ADVICE (as defined in FAIS COC Point
More informationGeneral Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.
General Chapter/Section: Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. of Commenters: 18 Editorial changes suggested by commenters have been reviewed by
More informationResponse to. GPhC Consultation. Guidance to ensure a safe and effective pharmacy team.
Response to GPhC Consultation on Guidance to ensure a safe and effective pharmacy team. Contact Helga Mangion National Pharmacy Association Mallinson House 38-42 St Peter s Street St Albans Herts AL1 3NP
More informationRESPONSE TO CESR S CONSULTATION PAPER ON POSSIBLE IMPLEMENTING MEASURES CONCERNING STORAGE AND FILING OF REGULATED INFORMATION (CESR /06-025)
Athens, March 22, 2006 Ref. No. 12735 CESR 11-13 Avenue de Friedland 75008 PARIS France Attention: M. F Demarigny Secretary General RESPONSE TO CESR S CONSULTATION PAPER ON POSSIBLE IMPLEMENTING MEASURES
More informationUKAS Guidance on the Application of ISO/IEC Dealing with Expressions of Opinions and Interpretations
LAB 13 Expression of opinions & interpretations UKAS Guidance on the Application of ISO/IEC 17025 Dealing with Expressions of Opinions and Interpretations [UKAS Publication ref: LAB 13] Contents Section
More informationThis memo includes background of the project, the major themes within the comments, and specific issues that require further CSAC/HITAC action.
TO: FR: RE: Consensus Standards Approval Committee (CSAC) Health IT Advisory Committee (HITAC) Helen Burstin, Karen Pace, and Christopher Millet Comments Received on Draft Report: Review and Update of
More informationChoose a fertility clinic: update
Choose a fertility clinic: update Strategic delivery: Setting standards Increasing and informing choice Demonstrating efficiency economy and value Details: Meeting Authority Agenda item 10 Paper number
More informationGlobal Harmonization Task Force SG3 Comments and Recommendations ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO and 13488
Page 1 of 6 Global Harmonization Task Force SG3 ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO 13485 and 13488 GENERAL COMMENTS The Global Harmonization Task Force Study Group Three (GHTF
More informationEUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL sante.ddg2.g.dir(2015)2952292 SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015
More informationTenant & Service User Involvement Strategy
Tenant & Service User Involvement Strategy Policy No: HM 07 Page: 1 of 9 Tenant & Service User Involvement Strategy 1. Introduction 1.1 Loreburn's Mission Statement is "Delivering Excellence" and we see
More informationREPORT FROM THE COMMISSION TO THE COUNCIL. on Directive 2011/64/EU on the structure and rates of excise duty applied to manufactured tobacco
EUROPEAN COMMISSION Brussels, 12.1.2018 COM(2018) 17 final REPORT FROM THE COMMISSION TO THE COUNCIL on Directive 2011/64/EU on the structure and rates of excise duty applied to manufactured tobacco EN
More informationYorkshire and the Humber Kidney Transplant Forum NOTES
Yorkshire and the Humber Kidney Transplant Forum Wednesday 11 November 2015 0900-1215 Waterton Park Hotel, Walton Hall, Walton, Wakefield, West Yorkshire, WF2 6PW NOTES AGENDA ITEMS 1. Welcome, Introductions,
More informationFrailty: Messages from the consultation by the Older People s Commission for Wales
Frailty: Messages from the consultation by the Older People s Commission for Wales October 2011 The Older People s Commissioner for Wales Cambrian Buildings Mount Stuart Square Bae Caerdydd / Cardiff Bay
More informationCOMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium
COMMENTS on a draft Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products Chemistry, Manufacturing, and Controls Documentation (Docket No. 99D-1454) Submitted by
More informationBE RECOGNIZED IN THE DEMOLITION INDUSTRY BECOME A MEMBER OF EDA
BE RECOGNIZED IN THE DEMOLITION INDUSTRY BECOME A MEMBER OF EDA What is EDA? 58% of companies noticed GROWTH in their business related to demolition in the past 3 years EDA Industry Report 2016 The European
More informationSupport to paediatric medicines development
Support to paediatric medicines development SME Info day Supporting innovative medicines development and early access Presented by Rocio Fernandez Human Medicines Research & Development Support Division
More informationVETERINARY SERVICES ACT (CAP. 437) Use and Marketing of Enzymes, Micro-organisms and their Preparations in Animal Nutrition Rules, 2006
L.N. 258 of 2006 B 3695 VETERINARY SERVICES ACT (CAP. 437) Use and Marketing of Enzymes, Micro-organisms and their Preparations in Animal Nutrition Rules, 2006 IN exercise of the powers conferred by article
More informationInvolvement of people affected
Involvement of people affected in the dossier assessment 1 1 Translation of the document Beteiligung von Betroffenen bei der Dossierbewertung (Version 1.1; Status: 28 July 2017). Please note: This translation
More informationKnowledge-Based Decision-Making (KBDM) to reach an Informed Group Conscience
Knowledge-Based Decision-Making (KBDM) to reach an Informed Group Conscience From the Service Manual page 52 - Group Conscience In order to make an informed group conscience decision, members need access
More informationChanges to Australian Government Hearing Services Program and Voucher scheme
Changes to Australian Government Hearing Services Program and Voucher scheme The Commonwealth Department of Health has published a report on its investigation into the future of the Hearing Services Program,
More informationMedicare Physician Fee Schedule Final Rule for CY 2018 Appropriate Use Criteria for Advanced Diagnostic Imaging Services Summary
Medicare Physician Fee Schedule Final Rule for CY 2018 Appropriate Use Criteria for Advanced Diagnostic Imaging Services Summary Background and Overview The Protecting Access to Medicare Act of 2014 included
More informationIMPORTANT DISCLAIMER. Note
yn EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL June 2012 DRAFT GUIDANCE DOCUMENT FOR COMPETENT AUTHORITIES FOR THE CONTROL OF COMPLIANCE WITH EU LEGISLATION ON: Regulation (EU) No 1169/2011
More informationWorking Document prepared by the Commission services - does not prejudice the Commission's final decision 3/2/2014 COMMISSION STAFF WORKING DOCUMENT
COMMISSION STAFF WORKING DOCUMENT on certain requirements for FSMPs [Supporting Document for the Expert Group meeting of 7 February 2014] Introduction Following the discussions in the Expert Group meeting
More informationBusiness Impact Analysis
ACTION: Final DATE: 05/23/2018 8:24 AM Business Impact Analysis Agency Name: Ohio Department of Medicaid (ODM) Regulation/Package Title: Dental services Rule Number(s): Rule 5160-5-01 with appendices A
More informationUSPSTF Draft Recommendations Investor Call. October 6, 2015
USPSTF Draft Recommendations Investor Call October 6, 2015 v Safe Harbor Statement Certain statements made in this presentation contain forward-looking statements within the meaning of Section 27A of the
More information10.2 Summary of the Votes and Considerations for Policy
CEPAC Voting and Policy Implications Summary Supplemental Screening for Women with Dense Breast Tissue December 13, 2013 The last CEPAC meeting addressed the comparative clinical effectiveness and value
More informationSelf-regulatory proposal from the european alcoholic beverages sectors on the provision of nutrition information and ingredients listing
Self-regulatory proposal from the european alcoholic beverages sectors on the provision of nutrition information and ingredients listing Disclaimer This common part of the proposal has been approved by
More informationThe ICHS1 Regulatory Testing Paradigm of Carcinogenicity in rats - Status Report
INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE The ICHS1 Regulatory Testing Paradigm of Carcinogenicity in rats - Status Report Introduction The ICH
More informationEnhanced Service for people with dementia in Primary Care
Enhanced Service for people with dementia in Primary Care Alistair Burns and Laurence Buckman September 2013 1 Summary The Enhanced Service for dementia, introduced in April 2013, is based in Primary Care
More informationConsultative report. Committee on Payments and Market Infrastructures. Board of the International Organization of Securities Commissions
Committee on Payments and Market Infrastructures Board of the International Organization of Securities Commissions Consultative report Governance arrangements for critical OTC derivatives data elements
More informationStudy Reveals Consumer Knowledge of Government Regulations
Study Reveals Consumer Knowledge of Government Regulations Washington, DC, June 16, 2017 This Ipsos study reveals consumer knowledge on government regulations of products and ads. 1. To the best of your
More informationThe call for compulsory hygiene rating displays for food outlets in England.
Briefing 16-35 September 2016 The call for compulsory hygiene rating displays for food outlets in England. Key issues Food Hygiene standards are a vitally important to ensure businesses maintain the highest
More informationLEAF Marque. Standard Setting. Public System Report
LEAF Marque Standard Setting Public System Report LEAF (Linking Environment And Farming) is a charity whose objectives are to promote and improve agriculture, horticulture and other types of farming and
More informationSUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD ON DECEMBER 2009 IN BRUSSELS (Section Animal Nutrition)
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL D(2009)411967 SUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD ON 17-18 DECEMBER 2009 IN BRUSSELS (Section Animal
More informationStaff Flu Campaign Evaluation Tool
Evaluation Tool Reviewing and evaluating your health and social care worker flu campaign The aim of this guide is to help you reflect and evaluate this year s health and/or social care worker influenza
More informationAuthor s response to reviews
Author s response to reviews Title: The validity of a professional competence tool for physiotherapy students in simulationbased clinical education: a Rasch analysis Authors: Belinda Judd (belinda.judd@sydney.edu.au)
More informationBasis for Conclusions: ISA 530 (Redrafted), Audit Sampling
Basis for Conclusions: ISA 530 (Redrafted), Audit Sampling Prepared by the Staff of the International Auditing and Assurance Standards Board October 2008 , AUDIT SAMPLING This Basis for Conclusions has
More informationChallenges in environmental risk assessment (ERA) for birds and mammals and link to endocrine disruption (ED) Katharina Ott, BASF SE, Crop Protection
Challenges in environmental risk assessment (ERA) for birds and mammals and link to endocrine disruption (ED) Katharina Ott, BASF SE, Crop Protection Charles River Symposium, Den Bosch, 3rd October 2017
More informationPROVIDER CONTRACT ISSUES
211 East Chicago Avenue T 312.440.2500 Chicago, Illinois 60611 F 312.440.7494 www.ada.org TOP 10 CLAIM CONCERNS: ADA, NADP SHARE VIEWS ON DENTISTS CONCERNS The ADA Council on Dental Benefit Programs continually
More informationSTANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 30 April 2012
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 30 April 2012 Chairmen: Mr Basil
More informationComparison Report For Kathryn Petersen Working with Martin Gilmore
Comparison Report For Kathryn Petersen Working with Gilmore Friday, March 25, 2016 This report is provided by: Wiley Workplace Learning Solutions R&D We appreciate your input! Introduction A cohesive team
More informationJICPA comments on the IESBA Exposure Draft, Proposed Revisions to the Code Pertaining to the Offering and Accepting of Inducements
The Japanese Institute of Certified Public Accountants 4-4-1 Kudan-Minami, Chiyoda-ku, Tokyo 102-8264, Japan Phone: 81-3-3515-1130 Fax: 81-3-5226-3355 Email: international@sec.jicpa.or.jp December 8, 2017
More informationPrice Correction Report Week of Nov 28- Dec 2, 2016
Overview This document is intended to meet the requirements of ISO Tariff section 35.6, and provides the Market Participants with a summary of all price corrections that occured during the week. For example,
More informationPrimer: Medical Device User Fee Amendments Han Zhong l September 2011
Primer: Medical Device User Fee Amendments Han Zhong l September 2011 Introduction The Medical Device User Fee and Modernization Act (MDUFMA or MDUFA) is a set of agreements between the Food and Drug Administration
More informationYoung Farmers Clubs of Ulster. Club Leader Role Description and Guidelines
Young Farmers Clubs of Ulster Club Leader Role Description and Guidelines Revised June 2005 Chapter 1 : Introduction As Club Leader you now have the primary leadership position in your club. The overall
More informationCritical Review Form Clinical Decision Analysis
Critical Review Form Clinical Decision Analysis An Interdisciplinary Initiative to Reduce Radiation Exposure: Evaluation of Appendicitis in a Pediatric Emergency Department with Clinical Assessment Supported
More informationMinistry of Children and Youth Services. Independent Clinical Review Process for the Ontario Autism Program. Guidelines
Ministry of Children and Youth Services Independent Clinical Review Process for the Ontario Autism Program Guidelines January 2018 Copies of this report can be obtained from: Ontario.ca/autism 2 Table
More informationSUBMISSION OF COMMENTS ON DRAFT COMMISSION PAEDIATRICS GUIDELINE
SUBMISSION OF COMMENTS ON DRAFT COMMISSION PAEDIATRICS GUIDELINE COMMENTS FROM Astellas Pharma Europe BV, Elisabethhof 19, 2353EW Leiderdorp, The Netherlands GENERAL COMMENTS A guiding document on the
More informationSheep Health Statement (SHS) Frequently Asked Questions
Sheep Health Statement (SHS) Frequently Asked Questions Q: What is the Sheep Health Statement? A: The Sheep Health Statement (SHS) is an important tool for allowing buyers of sheep to make an informed
More informationThe Performance Evaluation of Re-Circulating. Air LEV Systems
The Performance Evaluation of Re-Circulating Air LEV Systems Monday 24 th February 2014 Held at: Flextraction Ltd 10 Digby Drive Melton Mowbray Leicestershire LE13 1UT Speakers: Walter Gilder (WPG Paul
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
1997R0258 EN 07.08.2009 004.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B REGULATION (EC) No 258/97 OF THE EUROPEAN PARLIAMENT
More informationBusiness Requirements Definition. Project Nexus
Business Requirements Definition for Project Nexus submitted to Project Nexus Workgroup Annual Quantity (Distribution Workgroup from September 2016) Author (for this version): Xoserve Version: 6.0 Date:
More informationPrice Correction Report Week of November 26 November 30, 2018, 2017
Overview Price Correction Report This document is intended to meet the requirements of ISO Tariff section 35.6, and provides the Market Participants with a summary of all price corrections that occured
More informationTHE RESPONSIBLE PHARMACIST REGULATIONS
THE RESPONSIBLE PHARMACIST REGULATIONS A SUMMARY OF THE RESPONSES TO PUBLIC CONSULTATION ON PROPOSALS FOR THE CONTENT OF THE REGULATIONS DH INFORMATION READER BOX Policy HR / Workforce Management Planning
More informationKEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE
RNI Conseil 2017 Tous droits réservés Toute reproduction interdite sans l'autorisation de l'auteur. KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE Anne Laure TARDY, PhD
More informationECB-PUBLIC OPINION OF THE EUROPEAN CENTRAL BANK. of 11 April on a proposal for a regulation on the establishment of the European Monetary Fund
EN ECB-PUBLIC OPINION OF THE EUROPEAN CENTRAL BANK of 11 April 2018 on a proposal for a regulation on the establishment of the European Monetary Fund (CON/2018/20) Introduction and legal basis On 1 February
More informationFalsified Medicines Directive - Safety Features Update
Falsified Medicines Directive - Safety Features Update Catherine Neary GMP Conference 12 th November 2014 Agenda Background Delegated Act(s) Proposals Under Consideration White List & Black List Next Steps
More informationRegulatory incentives: Experience from European Medicines Agency
Regulatory incentives: Experience from European Medicines Agency European Medicines Agency Presented by: Nathalie Seigneuret An agency of the European Union EU Paediatric Regulation: Objectives Improve
More information